logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
W

William Jacot

Montpellier University
H指数:51
被引数:1.7万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Clinical features associated with exceptional response on first-line anti-HER2-based therapy for metastatic breast cancer: real-world data from the ESME national cohort

与转移性乳腺癌一线抗HER2为基础治疗中表现出非凡疗效相关的临床特征：来自ESME国家队列的真实世界数据

Breast
IF7.9
2026-10-130
OA
Thomas Grinda; Matthieu Carton; Stefania Morganti; Audrey Mailliez; Christelle Levy; Thierry Petit; Thomas Bachelot; Monica Arnedos; Véronique Diéras; Vincent Massard; Florence Dalenc; Isabelle Desmoulins; Jean-Yves Pierga; Anthony Gonçalves; Caroline Bailleux; Jean-Sebastien Frenel; Lise Bosquet; Heather A. Parsons; William Jacot; Nancy U. Lin
Chemotherapy outcomes in human epidermal growth factor receptor 2-low, hormone receptor-positive metastatic breast cancer: Insights from the French multicenter ESME database

人表皮生长因子受体2低表达、激素受体阳性转移性乳腺癌的化疗结局：来自法国多中心ESME数据库的见解

Breast
IF7.9
2026-09-270
OA
William Jacot; Pauline Macouillard; Suyuan Zhang; Danalyn Byng; Shannon Hunter; Vincent Massard; Jean-Sébastien Frenel; David Pérol; Etienne Brain; Audrey Mailliez; Thomas Bachelot; Monica Arnedos; Lise Bosquet; Véronique Diéras
Development and validation of a predictive model of aromatase inhibitor-induced arthralgia among patients with early breast cancer

早期乳腺癌患者中芳香化酶抑制剂诱导的关节痛预测模型的开发与验证

JNCI: Journal of the National Cancer Institute
IF0
2026-08-180
PRE
Pietro Lapidari, MD; Maryam Lustberg, MD, MPH; Julie Havas, MSc; Martina Pagliuca, MD; Chayma Bousrih, MD; Christelle Jouannaud, MD; Marion Fournier, MD; William Jacot, MD, PhD; Laurence Vanlemmens, MD; Kaderbhai Courèche, MD; Anne Kieffer, MD; Baptiste Sauterey, MD; Olivier Tredan, MD, PhD; Christelle Levy, MD; Anne-Laure Martin, PhD; Catherine Gaudin, BSc; Gwenn Menvielle, PhD; Maria Alice Franzoi, MD, PhD; Ines Vaz-Luis, MD, PhD; Antonio Di Meglio, MD, PhD
Risk stratification and relapse pattern in triple-negative breast cancer with pathological complete response after neoadjuvant treatment: the European GAMBIT real-world study
Nature Communications
IF15.7
2026-06-240
OAAI
Davide Massa; Theodoros Foukakis; Sylvie Giacchetti; Christine Desmedt; Jean-Sebastien Frenel; Elisa Gasparini; Marleen Kok; Paolo Vigneri; William Jacot; Claudio Vernieri; Matteo Lambertini; Francesca Patanè; Federico Piacentini; Emilio Bria; Alberto Zambelli; Dario Trapani; Andrea Botticelli; Ornella Garrone; Stefania Lando; Alexios Matikas; Laetitia Someil; Giuseppe Floris; Mario Campone; Moira Ragazzi; Esther Lips; Federica Martorana; Giorgio Bonomi; Andri Papakonstantinou; Lorenzo Nicolè; Ioannis Zerdes; Patrick Neven; Martina Rotolo; Hugo Horlings; Sabrina Nucera; Amélie Gudin-De-Vallerin; Andrea Vingiani; Angelo Paolo Dei Tos; Valentina Guarneri; Maria Vittoria Dieci
Tracking structural variants in early breast cancer using a high-sensitivity ctDNA assay predicts relapse in the post-neoadjuvant setting: the multicenter ALIENOR trial

利用高灵敏度ctDNA检测方法在早期乳腺癌中追踪结构变异，可预测新辅助治疗后的复发：多中心ALIENOR试验

ESMO Open
IF8.3
2026-06-040
OAAI
C. Blaye; F.-C. Bidard; L. Hue; K. Howarth; J.-Y. Pierga; F. Dalenc; W. Jacot; L. Djerroudi; W. Potonnier; V. Dumas; C. Lalet; M. Maréchal; M. Pulido; M. Brunet; L. Salabert; L. Venat; A. Maran-Gonzalez; L.H. Saal; C. Franchet; S. Birkeälv
Characteristics, treatment and survival of older patients with metastatic triple negative breast cancer from the ESME mBC real-world national cohort: a comparison with younger women

老年转移性三阴性乳腺癌患者的特征、治疗及生存情况：基于ESME mBC真实世界全国队列研究，并与年轻女性进行比较

The Breast
IF0
2026-05-220
OAAI
Mathilde Mairé; Fanny Bouteiller; Camille Chakiba; William Jacot; Romain Geiss; Mony Ung; Anthony Goncalves; Jean-Sébastien Frenel; Caroline Bailleux; Christophe Perrin; Vincent Massard; Audrey Mailliez; Christelle Jouannaud; François Cherifi; Thierry Petit; Catherine Terret; Alessandro Viansone; Lise Bosquet; Angéline Galvin
Characteristics and outcomes of patients with HER2-negative metastatic breast cancers with low expression of estrogen and progesterone receptors in the multicenter ESME cohort.

HER2阴性低表达雌激素和孕激素受体转移性乳腺癌患者的特征和结局：多中心ESME队列研究

The Breast
IF0
2026-05-180
OAAI
Marie Alexandre; Eva Teruel; Florence Dalenc; Thibaut de la Motte Rouge; Etienne Brain; Vincent Massard; Monica Arnedos; Audrey Mailliez; Jean-Marc Ferrero; Thomas Bachelot; Isabelle Desmoulins; Marie-Ange Mouret-Reynier; Christelle Levy; Antony Gonçalves; Anca Berghian; Thierry Petit; Jean-Sébastien Frenel; Anne-Laure Martin; Thomas Grinda; William Jacot
Recent treatment and survival trends in older versus younger women with HR-positive HER2-negative metastatic breast cancer in the real-life multicenter French ESME cohort

老年与年轻HR阳性HER2阴性转移性乳腺癌女性患者真实世界多中心法国ESME队列中的近期治疗与生存趋势

European Journal of Cancer
IF7.1
2025-12-050
PRE
Fanny Bouteiller; Sophie Gourgou; Michaël Bringuier; Angéline Galvin; Audrey Mailliez; Nicolas Bertrand; Mony Hung; Jean-Sébastien Frenel; Vincent Massard; Thomas Bachelot; Carole Plumio; Anthony Gonçalves; Christelle Levy; Lise Bosquet; William Jacot; Suzette Delaloge; Thomas Grinda; Carine Bellera
Trastuzumab deruxtecan in HER2-low metastatic breast cancer: long-term survival analysis of the randomized, phase 3 DESTINY-Breast04 trial

曲妥珠单抗德鲁替康在HER2低表达转移性乳腺癌中的应用：DESTINY-Breast04随机三期试验的长期生存分析

Nature Medicine
IF50
2025-10-080
OAAI
Shanu Modi; William Jacot; Hiroji Iwata; Yeon Hee Park; Maria Vidal Losada; Wei Li; Junji Tsurutani; Naoto T. Ueno; Khalil Zaman; Aleix Prat; Konstantinos Papazisis; Hope S. Rugo; Toshinari Yamashita; Nadia Harbeck; Seock-Ah Im; Michelino De Laurentiis; Jean-Yves Pierga; Xiaojia Wang; Andrea Gombos; Eriko Tokunaga; Cecilia Orbegoso Aguilar; Lotus Yung; Feng Xiao; Yingkai Cheng; David Cameron
Real-world treatment patterns and effectiveness after disease progression on CDK4/6 inhibitors for HR-positive/HER2-negative metastatic breast cancer in the ESME-MBC cohort

CDK4/6抑制剂治疗后疾病进展的HR阳性/HER2阴性转移性乳腺癌患者中真实世界的治疗模式与疗效：ESME-MBC队列研究

ESMO Open
IF8.3
2025-09-170
PREAI
R. Varnier; D. Pérol; W. Jacot; A. Mailliez; V. Diéras; F. Dalenc; A. Gonçalves; C. Levy; M. Arnedos; J.-S. Frenel; C. Bailleux; V. Massard; E. Brain; B. Sauterey; A.-M. Savoye; L. Bosquet; J.-C. Thery; T. Petit; T. Bachelot; T. Grinda; I. Ray-Coquard
Time-to-pregnancy in patients with previous breast cancer and unexposed women: a prospective exposed-unexposed cohort study

乳腺癌病史患者与未暴露女性：一项前瞻性暴露-未暴露队列研究中的受孕时间

eClinicalMedicine
IF10
2025-07-300
OA
Anne-Sophie Hamy; Agathe Chabassier; Clara Sebbag; Christine Rousset-Jablonski; Clémentine Berkach; Isabelle Ray-Coquard; Laura Sablone; Lauren Darrigues; Elise Dumas; Angélique Bobrie; William Jacot; Marc Espié; Sylvie Giacchetti; Floriane Jochum; Aullène Toussaint; Geneviève Plu-Bureau; Lorraine Maitrot-Mantelet; Anne Gompel; Paul Gougis; Raphaëlle Bas; Christine Decanter; Bernard Asselain; Charles Coutant; Lili Sohn; Guillemette Jacob; Claire Saule; Sophie Frank; Judith Abécassis; Florence Coussy; Fabien Reyal
Gene expression profiling in a retrospective real-world cohort of breast cancer brain metastases and paired primary tumors identifies biological changes with potential therapeutic implications

乳腺癌脑转移瘤及其配对原发肿瘤的回顾性真实世界队列基因表达谱分析，识别出具有潜在治疗意义生物学变化

ESMO Open
IF8.3
2025-07-230
PREAI
G. Griguolo; M.V. Dieci; S. Fineberg; C. Pinato; M. Bottosso; L. Bauchet; F. Miglietta; J. Jacob; V. Rigau; M.C. Guarascio; F. Zanconato; F. Schiavi; M. Fassan; A.P. Dei Tos; W. Jacot; S. Piccolo; A. Darlix; V. Guarneri
Temporal evolution of breast cancer brain metastases treatments and outcomes
NPJ BREAST CANCER
IF7.6
2025-02-200
OA
Bottosso, Michele; Griguolo, Gaia; Guiu, Severine; Guarascio, Maria Cristina; Bailleux, Caroline; Miglietta, Federica; Cattelan, Anna Chiara; Zurlo, Christian; Ferrero, Jean-Marc; Aldegheri, Vittoria; Falci, Cristina; Zanghi, Francesca; Giorgi, Carlo Alberto; Parisi, Alessandro; Vernaci, Grazia Maria; Girardi, Fabio; Jacot, William; Dieci, Maria Vittoria; Darlix, Amelie; Guarneri, Valentina
Prognostic value of tertiary lymphoid structures in triple-negative breast cancer: integrated analysis with the tumor microenvironment and clinicopathological features

三级淋巴结构在三阴性乳腺癌中的预后价值: 肿瘤微环境和临床病理特征的综合分析

FRONTIERS IN IMMUNOLOGY
IF5.9
2024-12-120
OAAI
Boissiere-Michot, Florence; Chateau, Marie-Christine; Thezenas, Simon; Lafont, Virginie; Crapez, Evelyne; Sharma, Priyanka; Bobrie, Angelique; Roger, Pascal; Guiu, Severine; Jacot, William

研究方向

暂未获取到该数据
F
Florence Dalenc
H 指数:55论文数:561被引数:1.6万
G
Gilles Romieu
H 指数:59论文数:379被引数:2.6万
C
Christelle Lévy
H 指数:46论文数:389被引数:1.0万
S
Séverine Guiu
H 指数:30论文数:175被引数:3,722
P
Pierre‐Jean Lamy
H 指数:36论文数:265被引数:4,761
A
Anthony Gonçalvès
H 指数:61论文数:729被引数:1.9万
S
Simon Thézenas
H 指数:35论文数:199被引数:5,332
T
Thomas Bachelot
H 指数:65论文数:556被引数:2.4万
M
Marc Debled
H 指数:42论文数:373被引数:8,154
S
Stéphane Pouderoux
H 指数:13论文数:77被引数:552